Beneficial Effects of Oral Nutritional Supplements on Body Composition and Biochemical Parameters in Women with Breast Cancer Undergoing Postoperative Chemotherapy: A Propensity Score Matching Analysis

Aim: Recently, more attention has been paid to the role of nutritional intervention in preventing the side effects of chemotherapy in oncology patients. Therefore, the aim of the present study was to analyze the effects of oral nutritional supplements on the body composition and biochemical parameters in women with breast cancer receiving postoperative adjuvant chemotherapy. Patients and Methods: The study involved women diagnosed with breast cancer who underwent surgical treatment and were qualified for chemotherapy (doxorubicin and cyclophosphamide). Women were divided into two groups, depending on whether oral nutritional supplements were used during chemotherapy. Anthropometric and biochemical parameters were analyzed twice in all patients: before and after six weeks of chemotherapy. Propensity score (PS) matching was performed to select patients balanced in terms of age, BMI, and clinicopathological features of the tumor. Statistical comparisons were conducted in a propensity-matched cohort of patients. Results: The value of BMI was maintained constant in the supplemented women older than 56 years after six weeks of chemotherapy. Regardless of age in the supplemented women, a significant increase in muscle mass, fat free mass (FFM), and fat free mass index (FFMI) was demonstrated. An increase in fat mass (FM) including visceral fat was observed only in the non-supplemented control. Regardless of age or initial FM, supplemented women exhibited a constant level of albumin. Moreover, in the supplemented women with normal initial FM, the stable values of triglycerides and HDL cholesterol were maintained after six weeks of chemotherapy. Conclusion: The present study demonstrated that oral nutritional supplements could improve body composition and prevent hypoalbuminemia and lipid abnormalities in women with breast cancer undergoing chemotherapy.

[1]  Guichun Jiang,et al.  The Effect of Nutrition Intervention With Oral Nutritional Supplements on Ovarian Cancer Patients Undergoing Chemotherapy , 2021, Frontiers in Nutrition.

[2]  Sara L. Thomas,et al.  Impact of Early Incorporation of Nutrition Interventions as a Component of Cancer Therapy in Adults: A Review , 2020, Nutrients.

[3]  Nan Zhang,et al.  Dynamic Changes of Blood Lipids in Breast Cancer Patients After (Neo)adjuvant Chemotherapy: A Retrospective Observational Study , 2020, International journal of general medicine.

[4]  Jun Han,et al.  Post-discharge oral nutritional supplements with dietary advice in patients at nutritional risk after surgery for gastric cancer: A randomized clinical trial. , 2020, Clinical nutrition.

[5]  C. Meskers,et al.  Pathophysiological mechanisms explaining poor clinical outcome of older cancer patients with low skeletal muscle mass , 2020, Acta physiologica.

[6]  K. Fichtali,et al.  Serum Lipidomic Profiling in Breast Cancer to Identify Screening, Diagnostic, and Prognostic Biomarkers , 2020, BioResearch open access.

[7]  J. Tooze,et al.  Hypoalbuminemia in children with cancer treated with chemotherapy , 2019, Pediatric blood & cancer.

[8]  S. Meuth,et al.  Skeletal muscle as potential central link between sarcopenia and immune senescence , 2019, EBioMedicine.

[9]  Maria Quaglietta,et al.  Nutrition and Breast Cancer: A Literature Review on Prevention, Treatment and Recurrence , 2019, Nutrients.

[10]  Jiabao Zhang,et al.  Emerging roles of low-density lipoprotein in the development and treatment of breast cancer , 2019, Lipids in Health and Disease.

[11]  Y. Xin,et al.  Effect of Early Nutrition Intervention on Advanced Nasopharyngeal Carcinoma Patients Receiving Chemoradiotherapy , 2019, Journal of Cancer.

[12]  Joon Seong Park,et al.  The Effect of Nutrition Intervention with Oral Nutritional Supplements on Pancreatic and Bile Duct Cancer Patients Undergoing Chemotherapy , 2019, Nutrients.

[13]  Mellar P. Davis,et al.  Sarcopenia associated with chemotherapy and targeted agents for cancer therapy. , 2019, Annals of palliative medicine.

[14]  Robert R. Wolfe,et al.  Hypoalbuminemia: Pathogenesis and Clinical Significance , 2018, JPEN. Journal of parenteral and enteral nutrition.

[15]  M. Couch,et al.  Preservation of muscle mass as a strategy to reduce the toxic effects of cancer chemotherapy on body composition , 2018, Current opinion in supportive and palliative care.

[16]  Bo Liu,et al.  Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis , 2018, Genes & diseases.

[17]  Jeffrey S. Damrauer,et al.  Chemotherapy-induced muscle wasting: association with NF-κB and cancer cachexia , 2018, European journal of translational myology.

[18]  Hao Li,et al.  Status of lipid and lipoprotein in female breast cancer patients at initial diagnosis and during chemotherapy , 2018, Lipids in Health and Disease.

[19]  V. Baracos,et al.  Systematic review and meta-analysis of the evidence for oral nutritional intervention on nutritional and clinical outcomes during chemo(radio)therapy: current evidence and guidance for design of future trials , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[20]  J. Ruiz-Rodríguez,et al.  Non-oncotic properties of albumin. A multidisciplinary vision about the implications for critically ill patients , 2018, Expert review of clinical pharmacology.

[21]  F. Corbella,et al.  Nutritional counseling with or without systematic use of oral nutritional supplements in head and neck cancer patients undergoing radiotherapy. , 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[22]  M. Ferry,et al.  Association between cachexia, chemotherapy and outcomes in older cancer patients: A systematic review. , 2017, Clinical nutrition.

[23]  S. McClave,et al.  Hypoalbuminemia and Clinical Outcomes: What is the Mechanism behind the Relationship? , 2017, The American surgeon.

[24]  N. Ueno,et al.  Association between weight gain during adjuvant chemotherapy for early‐stage breast cancer and survival outcomes , 2017, Cancer medicine.

[25]  B. Dong,et al.  The impact of frailty and sarcopenia on postoperative outcomes in older patients undergoing gastrectomy surgery: a systematic review and meta-analysis , 2017, BMC Geriatrics.

[26]  D. McMillan,et al.  Fish oil-enriched nutrition combined with systemic chemotherapy for gastrointestinal cancer patients with cancer cachexia , 2017, Scientific Reports.

[27]  Zeynep Canan Özdemir,et al.  Changes in Fibrinogen and Total Protein/Albumin Levels During Induction Chemotherapy in Children with Acute Lymphoblastic Leukemia Akut Lenfoblastik Lösemili Çocuklarda İndüksiyon Kemoterapisi Süresince Fibrinojen ve Total Protein/ Albumin Düzeyinde Meydana Gelen Değişiklikler , 2017 .

[28]  M. Hjermstad,et al.  Drug Dose Per Kilogram Lean Body Mass Predicts Hematologic Toxicity From Carboplatin‐Doublet Chemotherapy in Advanced Non–Small‐Cell Lung Cancer , 2017, Clinical lung cancer.

[29]  S. Burden,et al.  Pre‐operative oral nutritional supplementation with dietary advice versus dietary advice alone in weight‐losing patients with colorectal cancer: single‐blind randomized controlled trial , 2017, Journal of cachexia, sarcopenia and muscle.

[30]  K. Leroy,et al.  Sarcopenic overweight is associated with early acute limiting toxicity of anti-PD1 checkpoint inhibitors in melanoma patients , 2017, Investigational New Drugs.

[31]  P. Anandavadivelan,et al.  Sarcopenic obesity: A probable risk factor for dose limiting toxicity during neo-adjuvant chemotherapy in oesophageal cancer patients. , 2016, Clinical nutrition.

[32]  H. Muss,et al.  Prognostic value of sarcopenia in adults with solid tumours: A meta-analysis and systematic review. , 2016, European journal of cancer.

[33]  I. Nookaew,et al.  Voluntary Running Suppresses Tumor Growth through Epinephrine- and IL-6-Dependent NK Cell Mobilization and Redistribution. , 2016, Cell metabolism.

[34]  P. Novotny,et al.  Chemotherapy-induced nausea and vomiting: incidence and characteristics of persistent symptoms and future directions NCCTG N08C3 (Alliance) , 2016, Supportive Care in Cancer.

[35]  J. Ijzermans,et al.  Systematic review of sarcopenia in patients operated on for gastrointestinal and hepatopancreatobiliary malignancies , 2015, The British journal of surgery.

[36]  M. Correia,et al.  Nutritional and metabolic status of breast cancer women. , 2015, Nutricion hospitalaria.

[37]  A. Mohar,et al.  Effects of an oral nutritional supplement containing eicosapentaenoic acid on nutritional and clinical outcomes in patients with advanced non-small cell lung cancer: randomised trial. , 2014, Clinical nutrition.

[38]  M. Caplin,et al.  The role of dietary factors in prevention and progression of breast cancer. , 2014, Anticancer research.

[39]  Xingsheng Wang,et al.  Changes of serum albumin level and systemic inflammatory response in inoperable non-small cell lung cancer patients after chemotherapy. , 2014, Journal of cancer research and therapeutics.

[40]  B. Braun,et al.  Weight gain following breast cancer diagnosis: Implication and proposed mechanisms. , 2014, World journal of clinical oncology.

[41]  V. Vance,et al.  A comprehensive metabolic evaluation reveals impaired glucose metabolism and dyslipidemia in breast cancer patients early in the disease trajectory. , 2014, Clinical nutrition.

[42]  S. Lecleire,et al.  Impact of nutritional parameter variations during definitive chemoradiotherapy in locally advanced oesophageal cancer. , 2014, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[43]  V. Vance,et al.  Dietary changes and food intake in the first year after breast cancer treatment. , 2014, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.

[44]  Christiane,et al.  World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. , 2013, JAMA.

[45]  A. Stringer,et al.  Anti-Inflammatory Cytokines: Important Immunoregulatory Factors Contributing to Chemotherapy-Induced Gastrointestinal Mucositis , 2012, Chemotherapy research and practice.

[46]  R. Dantzer,et al.  Translational approaches to treatment-induced symptoms in cancer patients , 2012, Nature Reviews Clinical Oncology.

[47]  L. Oñate-Ocaña,et al.  Association of Nutrition Parameters Including Bioelectrical Impedance and Systemic Inflammatory Response With Quality of Life and Prognosis in Patients With Advanced Non-Small-Cell Lung Cancer: A Prospective Study , 2012, Nutrition and cancer.

[48]  M. Markman,et al.  Role of nutritional status in predicting quality of life outcomes in cancer – a systematic review of the epidemiological literature , 2012, Nutrition Journal.

[49]  B. Morio,et al.  Importance of metabolic changes induced by chemotherapy on prognosis of early‐stage breast cancer patients: a review of potential mechanisms , 2012, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[50]  D. S. St. Clair,et al.  Chemotherapy-induced weakness and fatigue in skeletal muscle: the role of oxidative stress. , 2011, Antioxidants & redox signaling.

[51]  E. L. da Silva,et al.  Dietary intake and oxidative stress in breast cancer: before and after treatments. , 2011, Nutricion hospitalaria.

[52]  Tuan V. Nguyen,et al.  More on body fat cutoff points. , 2011, Mayo Clinic proceedings.

[53]  V. Vance,et al.  Weight gain in breast cancer survivors: prevalence, pattern and health consequences , 2011, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[54]  A. Hevener,et al.  Sarcopenia Exacerbates Obesity-Associated Insulin Resistance and Dysglycemia: Findings from the National Health and Nutrition Examination Survey III , 2010, PloS one.

[55]  Rahul Dave,et al.  VARIOUS TYPES AND MANAGEMENT OF BREAST CANCER: AN OVERVIEW , 2010, Journal of advanced pharmaceutical technology & research.

[56]  M. Mouret-Reynier,et al.  Weight change during chemotherapy changes the prognosis in non metastatic breast cancer for the worse , 2010, BMC Cancer.

[57]  P. Boscolo-Rizzo,et al.  Early nutritional intervention improves treatment tolerance and outcomes in head and neck cancer patients undergoing concurrent chemoradiotherapy , 2010, Supportive Care in Cancer.

[58]  O. Arrieta,et al.  Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small cell lung cancer treated with paclitaxel-cisplatin chemotherapy: a prospective study , 2010, BMC Cancer.

[59]  C. Rock,et al.  Weight gain and recovery of pre-cancer weight after breast cancer treatments: evidence from the women’s healthy eating and living (WHEL) study , 2007, Breast Cancer Research and Treatment.

[60]  C. Visovsky.  Muscle Strength, Body Composition, and Physical Activity in Women Receiving Chemotherapy for Breast Cancer , 2006, Integrative cancer therapies.

[61]  C. Rock,et al.  Post-diagnosis weight gain and breast cancer recurrence in women with early stage breast cancer , 2006, Breast Cancer Research and Treatment.

[62]  B. Rosner,et al.  Weight, weight gain, and survival after breast cancer diagnosis. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[63]  B. Sternfeld,et al.  Life After Cancer Epidemiology (LACE) Study: A cohort of early stage breast cancer survivors (United States) , 2005, Cancer Causes & Control.

[64]  N. Pavlakis,et al.  Changes in body composition during breast cancer chemotherapy with the CMF‐regimen , 1999, Breast Cancer Research and Treatment.

[65]  Christiane,et al.  World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. , 2004, Journal international de bioethique = International journal of bioethics.

[66]  J. Grutsch,et al.  Is serum albumin an independent predictor of survival in patients with breast cancer? , 2003, JPEN. Journal of parenteral and enteral nutrition.

[67]  Wendy Demark-Wahnefried,et al.  Nutrition and survival after the diagnosis of breast cancer: a review of the evidence. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[68]  E. Winer,et al.  Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[69]  R. Kaaks,et al.  Energy balance and cancer: the role of insulin and insulin-like growth factor-I , 2001, The Proceedings of the Nutrition Society.

[70]  P. Goss,et al.  Estrogen and the risk of breast cancer. , 2001, The New England journal of medicine.

[71]  J. Rzymowska.  Effect of Cytotoxic Chemotherapy on Serum Lipid Levels in Breast Cancer Patients , 1999, Pathobiology.

[72]  E. Winer,et al.  Reduced rates of metabolism and decreased physical activity in breast cancer patients receiving adjuvant chemotherapy. , 1997, The American journal of clinical nutrition.

[73]  E. Winer,et al.  Weight gain in women diagnosed with breast cancer. , 1997, Journal of the American Dietetic Association.

[74]  T M Therneau,et al.  Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[75]  F. L. Baker,et al.  Breast cancer and weight gain: an unexpected finding. , 1978, Oncology nursing forum.